The EAU and the Confederación Americana de Urologia (CAU) held a joint meeting on March 2017 focused on a variety of topics that ranged from new insights on upper tract tumour conservative management, comparison of radical prostatectomy (RP) and radiation therapy (RT), robotic surgery in cystectomy, to focal therapy, and many others.
This Urology Beyond Europe session kicked off with the presentation of Prof. Alberto Briganti (IT) on RP versus RT for high-risk localized prostate cancer (PCa). He said surgery is the treatment of choice for aggressive PCa because RP allows individualized treatment, multimodal approach, decrease the rates of over-treatment, and no secondary malignancies for younger and healthier patients.
“In the absence of well-done randomized controlled trials (RCTs), RP should not be compared to RT with hormonal therapy (HT). However, RT + HT does not represent the standard treatment for locally advanced prostate cancer. RP alone can be curative for locally advanced patients,” said Briganti.
Source: European Association of Urology